Shop By A-Z  
 All Products
 By Category

Shop By Need
 Allergy
 Amino Acids
 Anti-Inflammation
 Antioxidants
 Brain / Memory
 CoEnzyme Q10
 Diabetes
 Diet Aids
 Digestion
 Energy
 Eye Health
 Heart / Cardio
 Immunity
 Joint / Bone
 Liver Health
 Men's Health
 Mental Health
 Minerals
 Multivitamins
 Omega-3's
 Pet Health
 Pill Boxes
 Resveratrol
 Senior Health
 Sexual Health
 Skin Care
 Sleep Support
 Sports Nutrition
 Stress Relief
 Vitamins
 Weight Loss
 Women's Health
ON ALL U.S. ORDERS OVER $75.00
SAME DAY SHIPPING; ORDER BY 4:00PM EST
DigiCert SSL Extended Validation Certificate

ABOUT SSL CERTIFICATES
 
Back Back
Share

AntiOxidant Ultra


AO1

AntiOxidant Ultra™, 600mg blend (120 capsules)
IN STOCK - YES
What is AntiOxidant Ultra?
What the heck is an antioxidant and why should I care? An antioxidant is a substance that reduces the oxidative damage caused by free radicals.

What are free radicals? Free radicals are unstable atoms or molecules with at least one unpaired electron. These atoms or molecules with unpaired electrons go looking for another electron to pair up with. If they find an electron, they take it. That makes them stable now, but it makes the atoms or molecules that they took the electron from, unstable. This makes for a new, Free Radical. Additionally, the serious damage from Free Radicals seems to come in the act of searching for, piercing into and taking electrons from cells. This 'oxidization' activity damages cell structures, particularly the cellular plasma membranes. Plasma cell membranes are natural gate keepers for cells, deciding what comes and goes within the cell. Damaging the plasma cell membrane and/or having the presence of free radicals in the cell, can damage the cell's ability to generate energy (in the mitochondria organelles), damage the cell's nucleus and/or damage the cell's DNA. Through this process the use and movement of nutrients, oxygen, water, waste products and toxins can also be hindered.
Who Should Consider AntiOxidant Ultra?
Everyone. Antioxidants are one of the best health supplements a person can take and an important part of a healthy nutritional regimen. We highly recommend antioxidants as part of a daily supplement regimen.

We created AntiOxidant Ultra™ as a collection of significant antioxidants to protect against oxidative damage to lipids, proteins, and DNA.

AntiOxidant Ultra™, 600mg blend (120 capsules)   AO1   (60 Day Supply)
AntiOxidant Ultra™, 600mg blend (120 capsules)
       
Retail
Buy 1 to 2
Buy 3 to 5
$66.50
$26.60
$23.28
$19.95
Buy more... Save more!

Quantity:     Frequency: 
To be sure you never run out of your favorite products, we now offer our exclusive Convenience Plan. This plan guarantees delivery of our high quality products directly to your door exactly when you need them. Additionally, you receive our lowest price on each order. It is simple, convenient and free! And, you can change, add to, suspend or cancel shipments at any time!
So how do we stop, or reduce the activities or impacts of free radicals? The answer is the aforementioned Antioxidants. Antioxidants inhibit the oxidization and/or the reactions that are caused by free radicals and by doing so, limit or stop the effects of Free Radicals.

Numerous scientific studies have concluded that by consuming foods and supplements which are rich in antioxidant properties, the incidence of diseases associated with the consequences of Free Radical oxidization can be reduced. This does not mean that these diseases can be cured, treated or prevented. Rather, it means that in scientific studies, people who consumed significant levels of antioxidants had lower incidences of these diseases including:
  • Prostate Cancer 1,2,3,4,5,6,7
  • Skin Cancer 8
  • Colon/Rectal Cancer 9,10
  • Heart Disease 11,12,13,14,15,16,17
  • Congestive Heart Failure 18
  • Stroke 19,20
  • Alcohol Induced Apoptosis or (literally, cell death common in alcoholics) 21
  • Advanced Macular Degeneration (AMD) 22
  • and other diseases and symptoms 23.
KEY INGREDIENTS

The key ingredients in Whole Health's AntiOxidant Ultra™ are described in detail below.

What is Green Tea Extract?

What is amazing about green tea is its reported ability to hinder the onset of many types of cancer. Much of the initial evidence that green tea is anti-carcinogenic is based on epidemiological studies which show lower rates of many types of cancer among populations such as Japan and China that drink green tea as part of a daily cultural habit. Recently, however, controlled studies on green tea extract have yielded impressive results, identifying the polyphenol (-)-epigallocatechin gallate (EGCG) as the responsible component. EGCG is able to force certain cancer cells into a situation in which, incredible as it may seem, they must die or be killed; the cancer cells die in a sort of cellular suicide, a condition scientists call 'apoptosis'. Further evidence shows EGCG as having an inhibitory effect on the enzyme, urokinase, which is required for tumor formation, thus preventing the formation of tumors in the first place. 26,27,30,31,32,33,36,37,38,39,40,41,42,44,45,46,47,48,49,55

Not only are the polyphenols in green tea protective against certain cancers, but they are also potent antioxidants. Green tea's antioxidants have been shown to be highly beneficial to the heart - they help prevent the oxidation of LDL cholesterol. 52,53,54,55,56

What Is OPC Grape Seed Extract?

OPC's (Oligomeric Proanthocyanidins) are a set of bioflavonoid complexes that perform as Free Radical scavengers in the human body. Many names refer to this set of bioflavonoids, including PCO's, Oligomeric Procyanidolic Complexes, leuco anthocyanin, anthocyanidin and still others. We will refer to them as OPCs for the duration of this discussion. OPC's are types of bioflavonoids, very powerful ones. Bioflavonoids are parts of plants that are actually assimilated into our body tissues when we consume them. OPC bioflavonoids were first noticed in the laboratory because they have the uncanny ability to strengthen blood vessel walls within hours after taking them.

What are Bilberry/Cranberry Extracts?

Bilberry Extract is the dry extract of the European Blueberry (Vaccinium myrtillus: Myrtilli fructus) and Cranberry is the red acidic fruit of the shrubby viburnum of North America and Europe.

Since AntiOxidant Ultra™ already has Green Tea and Grape Seed Extract, why add berries? Firstly because Bilberry has one of the highest oxygen radical absorbance capacities (ORAC) of any antioxidant, meaning its ability to hinder the damages of the oxygenization process is very strong.

Pre haps even more dramatic, Cranberry extract/press cake has been shown to slow the growth or metastasis of tumor cells, including liver cancer, breast cancer, lung cancer, skin cancer, colon cancer, prostate cancer and brain cancer cells. These studies have been done in vitro (in laboratory conditions) and are therefore preliminary until further research in the form of human in vivo (in the form of a living human body), double-blind placebo studies has been concluded. But the in vitro research is very encouraging and leads us to conclude that the inclusion of cranberry extract can have a potentially very positive impact.

What is Curcumin?

Curcumin is extracted from a large-leaved herb, closely related to ginger called the turmeric plant. Turmeric is a powerful antioxidant, anti-inflammatory and anti-hepatotoxic (good for the liver). 81 Recent studies with Curcumin have shown that it has the ability (once again in vitro) to kill cancer cells, this time head and neck cancer as well as gastric (stomach) cancer. 82,84 As with Bilberry and Cranberry, the studies are preliminary, but are very positive. Curcumin has also been shown to correct gene mutation Delta-F508, which produces an active, but mis-folded CFTR protein. Nearly 90% of people with Cystic Fibrosis carry at least one copy of the Delta-F508 CFTR gene. In research conducted by Yale professors Michael Caplan, M.D. and Marie Egan, M.D. and a colleague in Toronto, Gergely Lukacs, M.D., Curcumin corrected the Delta-F508 protein in vitro and in vivo (in mice). In fact, the mice regained normal lung function. 83,85

What is Milk Thistle Extract / Silybum marianum?

The seeds of the dried flower of the Milk Thistle plant (Silybum marianum), containing the active silymarin complex, including the component silibinin. Milk Thistle has been shown to have the following characteristics:
  1. Milk Thistle is a powerful Antioxidant. Like any bioflavonoid complex, Milk Thistle exerts a powerful positive anti-oxidant effect.
  2. Milk Thistle helps protect your liver. Milk Thistle may interrupt enterohepatic recirculation of toxins. The silymarin complex in Milk Thistle puts up a protective "shield" that may help protect against many liver-harming substances. 92
  3. Milk Thistle may help regenerate your liver. Did you know that your liver is the only internal organ in your body capable of regeneration? Milk Thistle's silymarin complex may actually help the liver to synthesize new proteins, vital in the regeneration process. 92


Side Effects
Always discuss any supplements or medications that you are taking with your physician . As these products and this combination have not been tested during pregnancy, do not use during pregnancy or while nursing. Milk thistle can cause some gastric distress for the first two days and then the symptoms should subside.

Label Facts


Supplement Facts
Serving Size: 2 Capsules
Servings per container: 60
Amount Per Serving % Daily Value
Green Tea Leaf Extract (Camellia sinenis) (40% Catechins) 200 mg †
Milk Thistle Seed Extract
(Silybum marianum) (80% Silymarin)		 100 mg †
Curcumin 90% Extract
(from Turmeric, Curcuma longa) 		100 mg †
Quercetin 100 mg †
Bromelain 2000 GDU (from Pineapple, Ananas comosus) 100 mg †
Cranberry Fruit Powder Extract (Vaccinium macrocarpon) 100 mg †
Rosemary Leaf Extract (Rosmarinus officinalis) 100 mg †
Grape Seed Extract (90% Polyphenols) 30 mg †
Ginkgo Biloba Leaf Extract (24% Ginkgoflavonglycosides) 30 mg †
Ginger Root (Zingiber officinalis) 30 mg †
Hawthorne Berry Extract
(Crataegus pinnatifida)
(1.8% bitexin-2'-rthamnoside)		 30 mg †
Bilberry Fruit Extract
(Vaccinium mytilus) (25% anthocyanidins)		 20 mg †
†Daily value not established.

   Other ingredients: Vegetable capsule (HPMC [cellulose], water), microcrystalline cellulose (plant fiber), and magnesium stearate (vegetable source).


Dietary Restrictions

Vegetarian capsule used and a vegetarian formula.  Vegetarian capsule used and a vegetarian formula.

References

  1. Hadley CW, Miller EC, Schwartz SJ, Clinton SK. Tomatoes, lycopene, and prostate cancer: progress and promise. Exp Biol Med ( Maywood). Nov 2002;227(10):869-880.
  2. Pastori M, Pfander H, Boscoboinik D, Azzi A. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun. 1998;250(3):582-585.
  3. Gann PH, Khachik F. Tomatoes or lycopene versus prostate cancer: is evolution anti-reductionist? J Natl Cancer Inst. Nov 5 2003;95(21):1563-1565.
  4. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. Mar 2004;13(3):340-345.
  5. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Canc Inst. 1995;87:1767-1776.
  6. Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst. 2001;93(24):1872-1879.
  7. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science. 1998;279:563-566.
  8. Millen AE, Tucker MA, et. Al. Diet and Melanoma in a Case Control Study, Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1042-51.
  9. Nkondjock A, Ghadirian P.. Dietary carotenoids and risk of colon cancer: case-control study. Int J Cancer 2004 May 20;110(1):110-6..
  10. Murtaugh MA, Ma KN, et al. Antioxidants, carotenoids, and risk of rectal cancer. Am J Epidemiol. 2004 Jan 1;159(1):32-41
  11. Kohlmeier L, Kark JD, GomezGracia E, et al. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol. 1997;146:618-626 12. Truswell AS. ABC of nutrition. Nutrition for pregnancy. Br Med J 1985;291:263-6.
  12. Klipstein-Grobusch K, Launer LJ, Geleijnse JM, Boeing H, Hofman A, Witteman JC. Serum carotenoids and atherosclerosis. The Rotterdam Study. Atherosclerosis. 2000;148(1):49-56.
  13. Rissanen TH, Voutilainen S, Nyyssonen K, et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2001;85(6):749-754.
  14. Rissanen TH, Voutilainen S, Nyyssonen K, Salonen R, Kaplan GA, Salonen JT. Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. Jan 2003;77(1):133-138.
  15. Kristenson M, Zieden B, Kucinskiene Z, et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ. 1997;314(7081):629-633.
  16. Sesso HD, Buring JE, Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr. Jan 2004;79(1):47-53.
  17. Sesso HD, Liu S, Gaziano JM, Buring JE. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr. Jul 2003;133(7):2336-2341
  18. Wood N, Johnson RB. The relationship between tomato intake and congestive heart failure risk in periodontitis subjects.J Clin Periodontol. 2004 Jul;31(7):574-80.
  19. Hak, A. Stroke: Journal of the American Heart Association, June 4, 2004; vol 35. News release, American Heart Association.
  20. Hak AE, Ma J, , et al. Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke , Stroke . 2004 Jun 3 .
  21. Xu Y, Leo MA, Lieber CS. Lycopene attenuates alcoholic apoptosis in HepG2 cells expressing CYP2E1. Biochem Biophys Res Commun. 2003 Aug 29;308(3):614-8.
  22. Simonelli F, Zarrilli F, Mazzeo S. Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. . Clin Chim Acta. 2002 Jun;320(1-2):111-5.
  23. Chew BP, Park JS. Carotenoid action on the immune response . J Nutr. 2004 Jan;134(1):257S-261S.
  24. Fuhrman B, Elias, A, et. al. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 1997; 233:658-662.
  25. Drs. Keith Ingold and Graham Burton. National Research Council of Canada.
  26. Venket Rao, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto.
  27. Annabi, B., M. P. Lachambre, N. Bousquet-Gagnon, M. Page, D. Gingras and R. Beliveau (2002). "Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells." Biochim Biophys Acta 1542(1-3): 209-20.
  28. Aucamp, J., A. Gaspar, Y. Hara and Z. Apostolides (1997). "Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis)." Anticancer Res 17(6D): 4381-5.
  29. Brown, M. D. (1999). "Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer." Altern Med Rev 4(5): 360-70.
  30. Higashi-Okai, K. and Y. Okai (1998). "Potent suppressive activity of chlorophyll a and b from green tea (Camellia sinensis) against tumor promotion in mouse skin." J Uoeh 20(3): 181-8.
  31. Jodoin, J., M. Demeule and R. Beliveau (2002). "Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols." Biochim Biophys Acta 1542(1-3): 149-59.
  32. Kapadia, G. J., B. D. Paul, E. B. Chung, B. Ghosh and S. N. Pradhan (1976). "Carcinogenicity of Camellia sinensis (tea) and some tannin-containing folk medicinal herbs administered subcutaneously in rats." J Natl Cancer Inst 57(1): 207-9.
  33. Katiyar, S. K., R. Agarwal, Z. Y. Wang, A. K. Bhatia and H. Mukhtar (1992). "(-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin." Nutr Cancer 18(1): 73-83.
  34. Katiyar, S. K. and H. Mukhtar (1997). "Tea antioxidants in cancer chemoprevention." J Cell Biochem Suppl 27: 59-67.
  35. Kavanagh, K. T., L. J. Hafer, D. W. Kim, K. K. Mann, D. H. Sherr, A. E. Rogers and G. E. Sonenshein (2001). "Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture." J Cell Biochem 82(3): 387-98.
  36. Mukhtar, H., Z. Y. Wang, S. K. Katiyar and R. Agarwal (1992). "Tea components: antimutagenic and anticarcinogenic effects." Prev Med 21(3): 351-60.
  37. Okai, Y. and K. Higashi-Okai (1997). "Potent suppressive activity of nonpolyphenolic fraction of green tea (Camellia sinensis) against genotoxin-induced umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002), tumor promotor-dependent ornithine decarboxylase induction of BALB/c 3T3 fibroblast cells, and chemically induced mouse skin tumorigenesis." Teratog Carcinog Mutagen 17(6): 305-12.
  38. Sakamoto, K. (2000). "Synergistic effects of thearubigin and genistein on human prostate tumor cell (PC-3) growth via cell cycle arrest." Cancer Lett 151(1): 103-9.
  39. Weisburger, J. H. (1997). "Tea and health: a historical perspective." Cancer Lett 114(1-2): 315-7.
  40. Shim, J. S., M. H. Kang, Y. H. Kim, J. K. Roh, C. Roberts and I. P. Lee (1995). "Chemopreventive effect of green tea (Camellia sinensis) among cigarette smokers." Cancer Epidemiol Biomarkers Prev 4(4): 387-91.
  41. Valcic, S., B. N. Timmermann, D. S. Alberts, G. A. Wachter, M. Krutzsch, J. Wymer and J. M. Guillen (1996). "Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines." Anticancer Drugs 7(4): 461-8.
  42. Yang, C. S., J. Y. Chung, G. Yang, S. K. Chhabra and M. J. Lee (2000). "Tea and tea polyphenols in cancer prevention." J Nutr 130(2S Suppl): 472S-478S.
  43. Yang, C. S., S. Prabhu and J. Landau (2001). "Prevention of carcinogenesis by tea polyphenols." Drug Metab Rev 33(3-4): 237-53.
  44. Hastak, K., S. Gupta, et al. (2003). "Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells." Oncogene 22(31): 4851-9.
  45. Rosengren, R. J. (2003). "Catechins and the treatment of breast cancer: Possible utility and mechanistic targets." IDrugs 6(11): 1073-8
  46. Pilorget, A., V. Berthet, et al. (2003). "Medulloblastoma cell invasion is inhibited by green tea (-)epigallocatechin-3-gallate." J Cell Biochem 90(4): 745-55.
  47. Lambert, J. D. and C. S. Yang (2003). "Mechanisms of cancer prevention by tea constituents." J Nutr 133(10): 3262S-3267S.
  48. Kemberling, J. K., J. A. Hampton, et al. (2003). "Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate." J Urol 170(3): 773-6.
  49. Einspahr, J. G., G. T. Bowden, et al. (2003). "Skin cancer chemoprevention: strategies to save our skin." Recent Results Cancer Res 163: 151-64; discussion 264-6.
  50. Adhami, V. M., N. Ahmad, et al. (2003). "Molecular targets for green tea in prostate cancer prevention." J Nutr 133(7 Suppl): 2417S-2424S.
  51. Ahn, W. S., S. W. Huh, et al. (2003). "A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression." DNA Cell Biol 22(3): 217-24.
  52. Morre, D. J., D. M. Morre, et al. (2003). "Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX)." Pharmacol Toxicol 92(5): 234-41.
  53. Fujiki, H., M. Suganuma, et al. (2003). "New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen." Mutat Res 523-524: 119-25.
  54. Katiyar, S. K. (2003). "Skin photoprotection by green tea: antioxidant and immunomodulatory effects." Curr Drug Targets Immune Endocr Metabol Disord 3(3): 234-42.
  55. Raederstorff, D. G., M. F. Schlachter, et al. (2003). "Effect of EGCG on lipid absorption and plasma lipid levels in rats." J Nutr Biochem 14(6): 326-32.
  56. Miura, Y., T. Chiba, et al. (2001). "Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice." J Nutr 131(1): 27-32.
  57. Osada, K., M. Takahashi, et al. (2001). "Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro." Comp Biochem Physiol C Toxicol Pharmacol 128(2): 153-64.
  58. Miura, S., J. Watanabe, et al. (1995). "Effects of various natural antioxidants on the Cu(2+)-mediated oxidative modification of low density lipoprotein." Biol Pharm Bull 18(1): 1-4.
  59. Miura, S., J. Watanabe, et al. (1994). "The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein." Biol Pharm Bull 17(12): 1567-72.
  60. Dulloo, A. G., C. Duret, D. Rohrer, L. Girardier, N. Mensi, M. Fathi, P. Chantre and J. Vandermander (1999). "Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans." Am J Clin Nutr 70(6): 1040-5.
  61. Stratton, S. P., R. T. Dorr, et al. (2000). "The state-of-the-art in chemoprevention of skin cancer." Eur J Cancer 36(10): 1292-7.
  62. Jerome L. Fleg, MD; Hidetaka Hougaku, M.D.; Edward G. Lakatta, M.D.; Mary K. Kemper; Christopher J. Earley, M.D.; and E. Jeffrey Metter, M.D. American Heart Association Scientific Sessions 2001.
  63. Pizzorno, Joseph, ND; Murray, Michael T, Eds. Textbook of Natural Medicine, second ed. Churchill Livingstone, 1999.
  64. Wang, Z., Y. Huang, J. Zou, K. Cao, Y. Xu and J. M. Wu (2002). "Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro." Int J Mol Med 9(1): 77-79.
  65. Abu-Amsha Caccetta, R., V. Burke, T. A. Mori, L. J. Beilin, I. B. Puddey and K. D. Croft (2001). "Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects." Free Radic Biol Med 30(6): 636-42.
  66. Clifford, A. J., S. E. Ebeler, J. D. Ebeler, N. D. Bills, S. H. Hinrichs, P. L. Teissedre and A. L. Waterhouse (1996). "Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids." Am J Clin Nutr 64(5): 748-56.
  67. de Vries, J. H., P. C. Hollman, I. van Amersfoort, M. R. Olthof and M. B. Katan (2001). "Red wine is a poor source of bioavailable flavonols in men." J Nutr 131(3): 745-8.
  68. Senault, C., D. Betoulle, G. Luc, P. Hauw, D. Rigaud and F. Fumeron (2000). "Beneficial effects of a moderate consumption of red wine on cellular cholesterol efflux in young men." Nutr Metab Cardiovasc Dis 10(2): 63-9.
  69. Takkouche, B., C. Regueira-Mendez, R. Garcia-Closas, A. Figueiras, J. J. Gestal-Otero and M. A. Hernan (2002). "Intake of wine, beer, and spirits and the risk of clinical common cold." Am J Epidemiol 155(9): 853-8.
  70. Nuttall, S. L., M. J. Kendall, E. Bombardelli and P. Morazzoni (1998). "An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect." J Clin Pharm Ther 23(5): 385-9.
  71. Preuss, H. G., D. Wallerstedt, N. Talpur, S. O. Tutuncuoglu, B. Echard, A. Myers, M. Bui and D. Bagchi (2000). "Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study." J Med 31(5-6): 227-46.
  72. Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M. Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem. 2003 Jan 1;51(1):68-75.
  73. Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK., Anti-angiogenic property of edible berries., Free Radic Res. 2002 Sep;36(9):1023-31.
  74. Bomser J, Madhavi DL, Singletary K, Smith MA. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med. 1996 Jun;62(3):212-6.
  75. Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr. 2004 Jun;134(6):1529-35.
  76. Seeram NP, Adams LS, Hardy ML, Heber D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem. 2004 May 5;52(9):2512-7.
  77. Murphy BT, MacKinnon SL, Yan X, Hammond GB, Vaisberg AJ, Neto CC. Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2003 Jun 4;51(12):3541-5.
  78. Sun J, Chu YF, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem. 2002 Dec 4;50(25):7449-54.
  79. Yan X, Murphy BT, Hammond GB, Vinson JA, Neto CC. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2002 Oct 9;50(21):5844-9.
  80. Kahkonen MP, Hopia AI, Heinonen M. Berry phenolics and their antioxidant activity. J Agric Food Chem. 2001 Aug;49(8):4076-82.
  81. Zheng S, Chen A. Activation of PPARgamma is required for curcumin to induce apoptosisand to inhibit the expression of extracellular matrix genes inhepatic stellate cell in vitro. Biochem J. 2004 Aug 23;Pt.
  82. Aggarwal et al., Inhibition of Growth and Survival of Human Head and Neck Squamous Cell Carcinoma Cells by Curcumin via Modulation of Nuclear Factor-kappaB Signalling. Int J Cancer. 2004 Aug 12;:NA.
  83. Accurso F., Curcumin and Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2004 Sep;39(3):235.
  84. Koo JY, Kim HJ, Jung KO, Park KY. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J Med Food. 2004 Summer;7(2):117-21.
  85. Caplan, Michael, M.D., Egan, Marie, M.D., Lukacs, Gergely, M.D, Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects, Science 2004 304: 600-602.
  86. Berkson, B. M. (1999). "A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories." Med Klin 94 Suppl 3: 84-9.
  87. Blumenthal, Mark; Goldberg, Alicia; Brinckmann, Josef, Eds,; Tyler, VarroE, PhD, ScD. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, 2000.
  88. Blumenthal, Mark; Busse, Werner R; Goldberg, Alicia; Gruenwald, Joerg, PhD; Hall, Tara; Riggins, Chance W.; Rister, Robert S., Eds, Klein, Sigrid, PhD; Rister, Robert S, Trans, Tyler, VarroE, PhD, ScD. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, 1998.
  89. Lapis, K., A. Jeney, et al. (1986). "Experimental studies on the effect of hepatoprotective compounds." Tokai J Exp Clin Med 11(Suppl): 135-45.
  90. Mourelle, M., P. Muriel, et al. (1989). "Prevention of CCL4-induced liver cirrhosis by silymarin." Fundam Clin Pharmacol 3(3): 183-91.
  91. Murray, Michael, ND; Pizzorno, Joseph, ND. Encyclopedia of Natural Medicine, second ed. Prima Publishing, Rocklin. 1999.
  92. Pizzorno, Joseph, ND; Murray, Michael T, Eds. Textbook of Natural Medicine, second ed. Churchill Livingstone, 1999.
  93. Benda, L., H. Dittrich, et al. (1980). "[The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)]." Wien Klin Wochenschr 92(19): 678-83.
  94. Tanasescu, C., S. Petrea, et al. (1988). "Use of the Romanian product Silimarina in the treatment of chronic liver diseases." Med Interne 26(4): 311-22.
  95. Ferenci, P., B. Dragosics, et al. (1989). "Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver." J Hepatol 9(1): 105-13.
  96. Wellington, K. and B. Jarvis (2001). "Silymarin: a review of its clinical properties in the management of hepatic disorders." BioDrugs 15(7): 465-89.


Senior Health
Antioxidants
Anti-Inflammation
Women's Health
top | previous page print this page
  Affiliate Program   Wholesale Inquiries   Convenience Plan   Site Map   Privacy Policy  
   1-866-381-7693
www.WholeHealth.com
This website and these statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Please consult a properly trained medical practitioner for medical advice.

Please read the Terms and Conditions of Using this Site. All Material at this site Copyright © 1997-2012
Whole Health Products, LLC All Rights Reserved.